drugset / Trial / NCT05963932
A Study to Assess the Bioavailability and Effect of Food of BMS-986419 Immediate-release Tablet Formulation in Healthy Adult Participants
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the impact of the BMS-986419 new immediate release (IR) tablet formulation compared to the current enteric (DR) capsule formulation, and to assess the effect of food on the drug levels of the IR tablet formulation in healthy adult participants.
Timeline
- Start
- 2023-08-08
- Primary completion
- 2023-10-17
- Completion
- 2023-10-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMS-986419 | Unknown | — | — |
Indications
No indication recorded.